Enerpac Tool Group Corp. (EPAC) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong organic sales growth and positive reception of new products, but is tempered by concerns over slightly declining EBITDA margins and restructuring costs. The Q&A reveals management's cautious stance on M&A and tariff impacts, with some uncertainty in financial guidance. Given the market cap, these mixed signals suggest a neutral stock price reaction.
Key Financial Performance
Revenue Enerpac's revenue increased 6% year-over-year to $159 million in Q3 2025. On an organic basis, adjusting for foreign exchange and the acquisition of DTA, the growth was 2%. The increase was driven by growth in both product sales (1%) and services (3%).
Cortland Biomedical Growth Cortland Biomedical reported a 19% growth year-over-year, driven by strong performance of existing products and market reception to new product launches, particularly in diagnostics, bioprocessing, and robotic surgery.
Gross Profit Margin Gross profit margin declined 140 basis points year-over-year to 50.4%. The decline was due to service project mix and the inclusion of DTA, partially offset by higher margins at Cortland Biomedical.
Adjusted SG&A Adjusted SG&A improved 160 basis points year-over-year to 25.5% of sales. This improvement was attributed to restructuring actions and standardization and automation of processes.
Adjusted EBITDA Adjusted EBITDA increased 3.4% year-over-year, but the margin declined 50 basis points to 25.9%. The decline in margin was due to the mix of service projects and the inclusion of DTA.
Adjusted Earnings Per Share Adjusted earnings per share increased 9% year-over-year to $0.51, driven by higher earnings, a lower effective tax rate, and reduced share count.
Net Debt Net debt was $50 million at the end of Q3 2025, resulting in a net debt to adjusted EBITDA ratio of 0.4.
Free Cash Flow Free cash flow increased 24% year-over-year to $40 million, despite $11 million in incremental capital spending, primarily associated with the headquarters relocation.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Cortland Biomedical new product launches: Strong market reception, particularly in diagnostics, bioprocessing, and robotic surgery.
Innovation lab at new headquarters: Invested in new equipment and technologies like 3D printers and CNC mills to accelerate innovation and R&D.
Heavy lifting technology from DTA acquisition: Added horizontal movement capability to existing vertical heavy lifting technology. Orders are robust, and backlog is expanding.
Geographic growth: Strong growth in the Americas (high single-digit) and APAC (mid-single-digit). EMEA faced a high single-digit decline due to economic slowdown and service revenue softness.
Vertical market performance: Strength in aerospace, infrastructure, nuclear, rail projects, solar farms, and wind projects. Weakness in steel (South Korea) and refining/petrochemicals (China).
Enerpac Commercial Excellence (ECX): Implemented to improve sales process and funnel management, contributing to above-market growth.
Service business margin improvement: Actions taken to focus on differentiated, value-added services and refine fixed cost base.
Headquarters relocation: Invested in automated manufacturing capabilities and innovation lab to improve efficiency and productivity.
Tariff impact mitigation: Implemented price increases and surcharges to offset tariffs. Exploring alternative suppliers to remain price/cost neutral.
Restructuring actions: $5.9 million restructuring charge to rightsize cost structure, including severance and lease impairment.
DTA acquisition strategy: Cross-selling DTA solutions across Enerpac's base and expanding sales beyond Europe.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Economic and geopolitical uncertainty: The company is taking a cautious posture entering the fourth quarter due to increasing levels of economic and geopolitical uncertainty, which could impact revenue and growth.
Soft market conditions: The industrial sector remains very soft, and the company anticipates delivering towards the lower half of its fiscal 2025 earnings guidance range.
Tariff impacts: The company faces an annualized tariff impact of $18 million, an incremental $12 million increase compared to fiscal 2024, along with additional cost pressures on U.S.-based suppliers importing components and raw materials.
Service margin pressure: Gross profit margin declined due to service project mix and the inclusion of DTA, despite sequential improvements from earlier actions.
Operational challenges with DTA acquisition: Deliveries from DTA have been slower to ramp than expected, requiring operational improvements to handle an expanded order book.
Softness in specific markets: The company is experiencing softness in the rail and general industrial manufacturing sectors in the Americas, the steel industry in South Korea, refining and petrochemicals in China, and service revenue in Europe.
Economic slowdown in Western Europe: The company is facing an overall economic slowdown in Western Europe, which is affecting service revenue.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Guidance for Fiscal 2025: Net sales are projected to be in the range of $610 million to $625 million, representing total revenue growth of 3% to 6% and organic growth of 0% to 2%. The company anticipates delivering towards the lower half of this range due to macroeconomic and geopolitical conditions.
Adjusted EBITDA Guidance for Fiscal 2025: Expected to be in the range of $150 million to $160 million, with expectations to deliver towards the lower half of the range.
Free Cash Flow Guidance for Fiscal 2025: Maintained at $85 million to $95 million for the full year.
Tariff Impact and Mitigation: The company estimates an annualized tariff impact of $18 million under the current framework, representing an incremental $12 million compared to fiscal 2024. Mitigation strategies include price increases, surcharges, and leveraging a global supply base to remain price/cost neutral.
Market Trends and Opportunities: Growth opportunities identified in solar farms in Vietnam, wind projects in Japan, and major rail projects in Thailand, Japan, and the Philippines. Strength observed in aerospace, infrastructure, and nuclear service industries in the Americas.
Innovation and R&D Investments: Significant investments in a new innovation lab at the Enerpac Center, including advanced equipment and technologies to accelerate product development and innovation.
DTA Acquisition and Integration: Operational improvements are ongoing to address slower-than-expected delivery ramp-up. Robust orders and expanding backlog are noted, with cross-selling strategies being implemented to expand sales beyond Europe.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Repurchase: In the third quarter, the company repurchased approximately 330,000 shares of common stock totaling $14 million. As we continue to generate cash, coupled with our current leverage, we have ample capacity to deploy capital for our disciplined M&A strategy as well as internal investments and continued opportunistic share repurchases.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Could you add some more color to what you're hearing from your customers in real time? And how are they managing or reacting to tariffs and macro uncertainty? Are they putting projects on hold? Have you seen an uptick in order cancellations?
A:Management stated that the environment is dynamic and varies by customer and end market. They have not seen meaningful project cancellations but noted that some customers are cautious about making large capital investments due to uncertainty. Companies still need to invest for capacity and growth. Pricing actions have been taken to offset inflationary impacts from tariffs, and channel partners are generally passing these costs along to customers.
Q:Did you see any revenue being pulled forward at all in Q3 in anticipation of tariffs? And what are your thoughts on inventory in the channel today?
A:Management observed a slight buy-in due to advanced notice of pricing actions but did not see anything hugely significant. No major concerns about inventory in the channel were mentioned.
Q:Could you provide any more additional detail regarding the restructuring actions during the quarter? And what is the anticipated cost savings?
A:The restructuring actions were driven by global uncertainty and geopolitical risks. Three-quarters of the costs were severance-related, and one-quarter was a noncash lease impairment charge due to a move to Downtown Milwaukee. Automation and process standardization are expected to help scale operations. No specific cost savings figures were provided.
Q:Were the pricing actions you took implemented in the quarter? And do you see the positive impact of those pricing actions going into effect in the quarter?
A:Pricing actions were taken in March and May, with some impact trickling in during the quarter. The real impact is expected in the upcoming fourth quarter.
Q:On the North American performance, up high single digits, what segments helped drive that performance?
A:Management highlighted good performance in aerospace and other diversified end markets. They emphasized the competitive advantage of serving a diverse set of customers and end markets.
Q:What are your thoughts on your wind business, especially with renewable energy credits potentially being on the chopping block?
A:Management remains positive about the wind market, particularly in Europe, where demand is stronger than in the U.S. Recent U.S. policy changes are seen as more favorable than initially expected. They continue to focus on core vertical markets, including infrastructure and rail.
Q:With the current tariff environment and a more sluggish industrial environment, have you seen any change in the appetite for M&A?
A:Management stated that there has been no change in their focus on M&A as part of their growth strategy. They remain disciplined in evaluating opportunities and are willing to walk away from deals that do not meet strategic and financial criteria.
Q:You provided a gross annualized tariff impact of $18 million. Is there any way to frame what the net impact of tariffs is expected to be in the fourth quarter and fiscal 2026?
A:Management aims to remain price-cost neutral despite tariff impacts. They have implemented a surcharge to flex with the market and maintain this balance.
Q:DTA sales were better than expected in the quarter but still trending below the EUR 20 million guidance. Has your expectation for the EUR 20 million guidance changed?
A:Management expects DTA to come in slightly below the EUR 20 million revenue guidance for the year. However, orders are strong and are tracking to more than EUR 20 million. Enerpac's operational discipline is helping improve DTA's throughput.
Q:How do U.S. tariffs on Europe impact DTA's cross-selling ability into the U.S.?
A:DTA products are subject to tariffs as they are produced in Spain. Despite this, there is strong demand from U.S. customers, and management remains optimistic about DTA's outlook in the U.S. market.
Q:Could you put some context around the pipeline size and scalability for the new in-house innovation lab? How does it compare to previous outsourced capabilities, and what is the potential impact on R&D costs?
A:The new innovation lab reduces prototyping time significantly, from weeks to days or hours. While some external services will still be used, the lab is expected to improve the pace of innovation and time-to-market for new products. Cost advantages are anticipated, but the primary benefit is faster innovation.
Q:How did Q3 play out compared to expectations regarding the focus on commercializing fiscal '24 launches versus new product innovation?
A:In Q3, the company focused on commercializing fiscal '24 product launches while also introducing new products, such as a rail industry solution for pulling nails out of bridges. They continue to balance commercialization efforts with new product development, particularly in key verticals.
Q:Review of Unclear Management Responses
A:Management avoided providing specific cost savings figures for the restructuring actions and did not quantify the net impact of tariffs for the fourth quarter and fiscal 2026. Additionally, while they discussed the positive outlook for the wind market and M&A strategy, their responses lacked detailed data or concrete examples to fully substantiate their claims.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Associates Inc
Biomedical DTA
Biomedical pressure
Blair LLC
CEO President
CFO CEO
Center Downtown
China
Japan
Kozik
Netherlands
Research Division
Slide
addition
cost structure
country
efficiency
headquarters relocation
inclusion DTA
majority
manufacturing
margin basis
market condition
market perspective
product portfolio
project mix
rail
region digit
restructuring charge
service project
softness
strength
supplier
uncertainty
wind project
EPAC Transcript
Enerpac Tool Group Corp. (EPAC) Q2 2026 Earnings Call Transcript
Positive3-26
The earnings call highlights strong organic sales growth in the Industrial Tools & Service segment, marking the highest product growth experienced by the company. This is a strong positive indicator, despite risks mentioned in forward-looking statements. The absence of any significant negative feedback or unclear responses in the Q&A further supports a positive sentiment. Given the company's market cap, the stock price is likely to see a positive movement of 2% to 8% over the next two weeks.
Enerpac Tool Group Corp. (EPAC) Q1 2026 Earnings Call Transcript
Positive12-18
The earnings call revealed positive aspects such as a shift to higher-margin services, strong R&D investment, and solid growth in Cortland Biomedical. The Q&A section highlighted strategic moves to enhance service value and product innovation, despite some market softness and unclear details on certain initiatives. The company's positive guidance, increase in free cash flow, and low net debt-to-EBITDA ratio further support a positive outlook. Given the market cap, the stock price is likely to react positively, but not overwhelmingly, resulting in a 'Positive' prediction (2% to 8%).
Enerpac Tool Group Corp. (EPAC) Q4 2025 Earnings Call Transcript
Positive10-16
Despite challenges in the EMEA market, the company showed strong growth in adjusted EBITDA and EPS, and maintained a solid cash flow. The DTA integration is progressing well, and the global rollout of e-commerce is promising. The optimistic guidance for fiscal '26, strong M&A outlook, and a $200 million share repurchase program further support a positive sentiment. However, the cautious growth outlook and macroeconomic uncertainties temper expectations, resulting in a positive but not strong positive prediction.
Enerpac Tool Group Corp. (EPAC) Q3 2025 Earnings Call Transcript
Unknown6-27
The earnings call highlights strong organic sales growth and positive reception of new products, but is tempered by concerns over slightly declining EBITDA margins and restructuring costs. The Q&A reveals management's cautious stance on M&A and tariff impacts, with some uncertainty in financial guidance. Given the market cap, these mixed signals suggest a neutral stock price reaction.
EPAC Slides
EPAC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
